Clinical Trials
5 trialsNCT04459078 2022-12-02
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Hunan Cancer Hospital
Phase 2 Unknown
NCT05507606 2022-08-19
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05273814 2022-07-13
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT04137588 2021-02-24
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Unknown
NCT03461185 2018-03-09
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing
Phase 2 Unknown